Benekli M - Search Results

1

Bevacizumab-containing chemotherapy is safe in patients with unresectable metastatic colorectal cancer and a synchronous asymptomatic primary tumor.

Cetin B, Kaplan MA, Berk V, Tufan G, Benekli M, Isikdogan A, Ozkan M, Coskun U, Buyukberber S. Cetin B, et al. Among authors: benekli m. Jpn J Clin Oncol. 2013 Jan;43(1):28-32. doi: 10.1093/jjco/hys175. Epub 2012 Oct 28. Jpn J Clin Oncol. 2013. PMID: 23107836

2

Capecitabine plus oxaliplatin (xelox) in the treatment of chemotherapy-naive patients with metastatic colorectal cancer.

Yaman E, Uner A, Er O, Coskun U, Buyukberber S, Dikilitas M, Polat M, Yamac D, Kaya AO, Yildiz R, Ozturk B, Benekli M. Yaman E, et al. Among authors: benekli m. Med Oncol. 2007;24(4):431-5. doi: 10.1007/s12032-007-0035-7. Med Oncol. 2007. PMID: 17917094 Clinical Trial.

3

Gemcitabine plus capecitabine combination in metastatic breast cancer patients previously treated with anthracyclines and taxanes.

Benekli M, Yildiz R, Uner A, Er O, Yamac D, Alkis N, Coskun U, Camci C, Buyukberber S. Benekli M, et al. Oncology. 2007;72(5-6):308-13. doi: 10.1159/000113053. Epub 2008 Jan 14. Oncology. 2007. PMID: 18198492

4

Bevacizumab plus irinotecan-based therapy in metastatic colorectal cancer patients previously treated with oxaliplatin-based regimens.

Yildiz R, Buyukberber S, Uner A, Yamac D, Coskun U, Kaya AO, Ozturk B, Yaman E, Benekli M. Yildiz R, et al. Among authors: benekli m. Cancer Invest. 2010 Jan;28(1):33-7. doi: 10.3109/07357900802562996. Cancer Invest. 2010. PMID: 19995229

5

The effect of bevacizumab on serum soluble FAS/FASL and TRAIL and its receptors (DR4 and DR5) in metastatic colorectal cancer.

Yildiz R, Benekli M, Buyukberber S, Kaya AO, Ozturk B, Yaman E, Berk V, Coskun U, Yamac D, Sancak B, Uner A. Yildiz R, et al. Among authors: benekli m. J Cancer Res Clin Oncol. 2010 Oct;136(10):1471-6. doi: 10.1007/s00432-010-0803-1. Epub 2010 Feb 13. J Cancer Res Clin Oncol. 2010. PMID: 20155284

6

Synchronous bilateral breast cancer in a patient with kindler syndrome.

Tonyali O, Tufan G, Benekli M, Coskun U, Buyukberber S. Tonyali O, et al. Among authors: benekli m. Clin Breast Cancer. 2012 Apr;12(2):145-6. doi: 10.1016/j.clbc.2011.09.003. Epub 2011 Nov 4. Clin Breast Cancer. 2012. PMID: 22054710 No abstract available.

7

Prognostic factors for overall survival in patients with metastatic colorectal carcinoma treated with vascular endothelial growth factor-targeting agents.

Cetin B, Kaplan MA, Berk V, Ozturk SC, Benekli M, Isıkdogan A, Ozkan M, Coskun U, Buyukberber S. Cetin B, et al. Among authors: benekli m. Asian Pac J Cancer Prev. 2012;13(3):1059-63. doi: 10.7314/apjcp.2012.13.3.1059. Asian Pac J Cancer Prev. 2012. PMID: 22631638 Free article.

8

Bevacizumab every 4 weeks is as effective as every 2 weeks in combination with biweekly FOLFIRI in metastatic colorectal cancer.

Yildiz R, Benekli M, Ozkan M, Alkis N, Berk V, Kaplan MA, Ciltas A, Karaca H, Durnali AG, Coskun U, Dikilitas M, Sevinc A, Dane F, Yetisyigit T, Dogu GG, Buyukberber S. Yildiz R, et al. Among authors: benekli m. J Cancer Res Clin Oncol. 2012 Nov;138(11):1845-52. doi: 10.1007/s00432-012-1264-5. Epub 2012 Jun 22. J Cancer Res Clin Oncol. 2012. PMID: 22722713

9

Nine-week trastuzumab treatment versus 52-week trastuzumab treatment for HER2-positive early-stage breast cancer.

Tonyali O, Coskun U, Sener N, Inanc M, Akman T, Oksuzoglu B, Ozdemir NY, Yazilitas D, Benekli M, Uner A, Yamac D, Demirci U, Yildiz R, Karaca H, Unal OU, Bal O, Gumus M, Buyukberber S; Anatolian Society of Medical Oncology (ASMO). Tonyali O, et al. Among authors: benekli m. J Cancer Res Clin Oncol. 2012 Dec;138(12):2145-51. doi: 10.1007/s00432-012-1296-x. Epub 2012 Aug 10. J Cancer Res Clin Oncol. 2012. PMID: 22878681

10

Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected liver metastases from colorectal cancer.

Turan N, Benekli M, Koca D, Ustaalioglu BO, Dane F, Ozdemir N, Ulas A, Oztop I, Gumus M, Ozturk MA, Berk V, Kucukoner M, Uner A, Balakan O, Helvaci K, Ozkan S, Yilmaz U, Buyukberber S; Anatolian Society of Medical Oncology. Turan N, et al. Among authors: benekli m. Oncology. 2013;84(1):14-21. doi: 10.1159/000342429. Epub 2012 Oct 16. Oncology. 2013. PMID: 23076023

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

199 results

Search Page

Filters